Skip to Content
Stream Live
More Streaming Options
ON AIR
Recently Played
View Full Playlist
SUPPORT
‹ All Events

Biosimilars in the EU MasterClass

SUPPORT

The market share of drug products manufactured by means of modern biotechnology is constantly increasing. In Germany, it is close to 25% in value. This means that there will be a major cost saving potential for the healthcare systems by introduction of Biosimilar competition. New therapeutic options are opened for treatment of severe medical conditions and it is obvious that this product category will become even more important in the future. Consequently, it is vital for generic pharmaceutical companies to consider extending their business scope from drug products with classical chemically synthetized API to Biosimilars. The training aims to create deeper understanding why biotechnological products – and as a consequence biosimilars – are a unique product category and what aspects have to be considered in R&D and Drug Regulatory Affairs.

More Lectures & Presentations

Wall City: Painting for the People
Wall City: Painting for the People
March 3 | 6:00 pm - 7:00 pm
Online
From Sanatoriums to Sun City
From Sanatoriums to Sun City
March 10 | 6:00 pm - 7:30 pm
Online
March 18 | 5:30 pm
Online

More Events

KXCI NEWSLETTER

Sign Up

SUPPORT
LOCAL RADIO

SUPPORT